A partir d'une revue de la littérature (240 articles), cette étude identifie et analyse les facteurs associés à l'utilisation, par les enfants et les adolescents, de systèmes électroniques de délivrance de la nicotine (SEDEN) et/ou de cigarettes électroniques sans nicotine

Factors associated with child and adolescent electronic nicotine and non-nicotine delivery systems use: A scoping review

Barnes, Courtney ; McCrabb, Sam ; Bialek, Caitlin ; Turon, Heidi ; Dray, Julia ; Duffy, Megan ; Lane, Cassandra ; Lum, Melanie ; Brown, Alison ; Doyle, Jodie ; Wolfenden, Luke

Objectives To identify, characterise and broadly synthesise factors associated with child and adolescent electronic nicotine delivery systems (ENDS) and/or electronic non-nicotine delivery systems (ENNDS) ever-use and/or current use. Methods: Four electronic databases were searched from inception to 3rd June 2022. Non-experimental studies that provided quantitative factors associated with adolescent and/or child ENDS or ENNDS ever-use and/or current use were included. Factors associated with [...]

Menée aux Etats-Unis à partir de données portant sur 5 653 patientes atteintes d'un cancer du sein, cette étude analyse leurs comportements tabagiques en fonction de leur lieu de naissance, de leur origine ethnique et de leur niveau d'éducation

Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer

Uong, Stephen P. ; Torres, Jacqueline M. ; Alexeeff, Stacey E. ; Morey, Brittany N. ; Caan, Bette J. ; Kushi, Lawrence H. ; Kroenke, Candyce H.

Background: We evaluated smoking differences across nativity and race/ethnicity among women diagnosed with breast cancer. Methods: In our Northern Californian pooled population of 5,653 [670 Asian, 690 Hispanic, and 4,300 Non-Hispanic White (White)] women diagnosed with breast cancer, we evaluated smoking differences across nativity, race/ethnicity, and acculturation and effect modification of nativity by race/ethnicity and education. Results: Foreign-born women currently smoked less than [...]

Menée à partir de données portant sur 209 patients atteints d'un cancer du poumon et sur 406 témoins, cette étude analyse l'association entre le niveau plasmatique des tocophérols (vitamine E) et le risque de développer la maladie en fonction de l'origine ethnique

Associations between Plasma Tocopherols and Lung Cancer Risk: Results from the Southern Community Cohort Study

Yoon, Hyung-Suk ; Wu, Jie ; Shidal, Chris ; Sun, Yan ; Franke, Adrian A. ; Yang, Jae Jeong ; Braithwaite, Dejana ; Courtney, Regina ; Cai, Hui ; Blot, William J. ; Shu, Xiao-Ou ; Zheng, Wei ; Cai, Qiuyin

Background: Despite the various anticancer activities of tocopherols, little is known about tocopherols associated with lung cancer risk among low-income African Americans (AA) and European Americans (EA) who are disproportionately affected by the disease. Methods: We conducted a nested case–control study that included 209 incident lung cancer cases and 406 matched controls within the Southern Community Cohort Study. Using biospecimens collected at cohort enrollment, plasma levels of  [...]

Menée en Suède et au Danemark à partir de données portant sur 11 874 patientes atteintes d'un cancer de l'ovaire (âge : 30-84 ans) et sur 473 960 témoins, cette étude analyse l'association entre une utilisation de faibles doses d'aspirine et le risque de développer la maladie

Low-dose aspirin use and risk of ovarian cancer: a combined analysis from two nationwide studies in Denmark and Sweden

Zheng, Guoqiao ; Faber, Mette Tuxen ; Wang, Jiangrong ; Baandrup, Louise ; Hertzum-Larsen, Rasmus ; Sundström, Karin ; Kjær, Susanne K.

Background: Studies on association between low-dose aspirin use and ovarian cancer risk were mostly based on self-reported medication use and few had large enough sample size to investigate the potential modification effect by ovarian cancer risk factors. Methods: In these two nationwide nested case-control studies among the Danish and Swedish female population, 11,874 women with ovarian cancer (30–84 years old) (Denmark: 7328 diagnosed in 2000–2019, Sweden: 4546 diagnosed in 2010–2018) were [...]

Menée dans un contexte américain, cette étude estime le rapport coût-efficacité d'une utilisation de tests multigéniques (BRCA1, BRCA2, and PALB2) chez l'ensemble des femmes de 30 à 35 ans afin de mettre en place, si nécessaire, une stratégie de prévention du risque de cancer du sein ou de l'ovaire (IRM avec ou sans mammographie, chimioprévention, mastectomie prophylactique, salpingo-ovariectomie prophylactique)

Cost-Effectiveness of Population-Based Multigene Testing for Breast and Ovarian Cancer Prevention

Guo, Fangjian ; Adekanmbi, Victor ; Hsu, Christine D. ; Berenson, Abbey B. ; Kuo, Yong-Fang ; Shih, Ya-Chen Tina

Importance : The current method of BRCA testing for breast and ovarian cancer prevention, which is based on family history, often fails to identify many carriers of pathogenic variants. Population-based genetic testing offers a transformative approach in cancer prevention by allowing for proactive identification of any high-risk individuals and enabling early interventions. Objective : To assess the lifetime incremental effectiveness, costs, and cost-effectiveness of population-based multigene [...]

Menée en France en 2022 par questionnaire auprès de 360 médecins généralistes, cette étude analyse leurs pratiques concernant la vaccination des garçons âgés de 11 à 19 ans contre le papillomavirus humain

Practices of French General Practitioners Regarding Vaccination of Boys Against Human Papillomavirus (HPV), One Year After the Application of Its Official Recommendation

Hurtaud, Aline ; Tara, Alexandre Abou ; Bouazzi, Leïla ; Pacquelet, Yannick ; Boiteux-Chabrier, Marie ; Pham, Bach-Nga ; Pierre Cavard, Hélène ; Barbe, Coralie

In 2019, French health authorities extended the recommendation for human papillomavirus (HPV) vaccination to include boys aged 11 to 19 years. We describe HPV vaccination practices among French general practitioners (GPs) since this recommendation wasapplied. We also identified factors associated with the propensity to propose HPV vaccination to boys. Cross-sectional study, between May and August 2022, among French GPs using a questionnaire asking about the GPs, their practices, and opinions [...]

Menée au Royaume-Uni, cette étude de cohorte compare le rapport coût-efficacité de stratégies de prévention du cancer du sein et de l'ovaire (salpingo-ovariectomie et mastectomie prophylactiques versus interventions non chirurgicales) chez des femmes porteuses de variants sur des gènes de susceptibilité à la maladie (BRCA, PALB2, RAD51C, RAD51D et BRIP1)

Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer

Wei, Xia ; Sun, Li ; Slade, Eric ; Fierheller, Caitlin T. ; Oxley, Samuel ; Kalra, Ashwin ; Sia, Jacqueline ; Sideris, Michail ; McCluggage, W. Glenn ; Bromham, Nathan ; Dworzynski, Katharina ; Rosenthal, Adam N. ; Brentnall, Adam ; Duffy, Stephen ; Evans, D. Gareth ; Yang, Li ; Legood, Rosa ; Manchanda, Ranjit

Importance : Pathogenic variants (PVs) in BRCA1, BRCA2, PALB2, RAD51C, RAD51D, and BRIP1 cancer susceptibility genes (CSGs) confer an increased ovarian cancer (OC) risk, with BRCA1, BRCA2, PALB2, RAD51C, and RAD51D PVs also conferring an elevated breast cancer (BC) risk. Risk-reducing surgery, medical prevention, and BC surveillance offer the opportunity to prevent cancers and deaths, but their cost-effectiveness for individual CSGs remains poorly addressed. Objective : To estimate the [...]